Rise Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-773
Closed -$73.6K 896
2025
Q3
$73.6K Buy
773
+23
+3% +$2.11K 0.03% 199
2025
Q2
$65.4K Sell
750
-594
-44% -$50.4K 0.03% 206
2025
Q1
$121K Buy
1,344
+649
+93% +$58.1K 0.05% 129
2024
Q4
$55.5K Sell
695
-50
-7% -$4.33K 0.03% 209
2024
Q3
$67.1K Buy
745
+7
+0.9% +$589 0.03% 190
2024
Q2
$58.1K Buy
738
+55
+8% +$4.51K 0.03% 212
2024
Q1
$59.5K Buy
683
+679
+16,975% +$57.9K 0.03% 205
2023
Q4
$369 Sell
4
-29
-88% -$2.21K ﹤0.01% 577
2023
Q3
$2.56K Buy
33
+1
+3% +$84 ﹤0.01% 439
2023
Q2
$2.86K Hold
32
﹤0.01% 476
2023
Q1
$2.6K Sell
32
-78
-71% -$6.36K ﹤0.01% 538
2022
Q4
$8.58K Sell
110
-500
-82% -$40.5K 0.01% 371
2022
Q3
$49K Buy
610
+486
+392% +$43.7K 0.04% 156
2022
Q2
$11K Hold
124
0.01% 334
2022
Q1
$14K Sell
124
-13
-9% -$1.37K 0.01% 293
2021
Q4
$14.1K Buy
+137
New +$15.9K 0.01% 286

Other funds holding MDT

Rise Advisors's MDT Position: Q4 2025 in Review

Rise Advisors sold out of Medtronic (MDT) in Q4 2025, closing a stake of 773 shares — an estimated $73.6K sold.

Rise Advisors first reported a position in MDT in Q4 2021 and held it in 16 quarters. The position peaked at $121K in Q1 2025. 2,312 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Rise Advisors reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 773 Medtronic shares in Q4 2025, an estimated $73.6K.
  • Rise Advisors first reported a position in Medtronic in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's Medtronic position peaked at $121K in Q1 2025.
  • 2,312 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.